Innate Pharma Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LION POINT CAPITAL, LP | 05/15/2026 | 81.15 K | $103.87 K | 0.00% | 0.09% |
| MORGAN STANLEY | 05/15/2026 | 43.52 K | $55.71 K | -6.19% | 0.05% |
| JANE STREET GROUP, LLC | 05/12/2026 | 43.37 K | $55.51 K | -53.25% | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 10.06 K | $12.88 K | -50.44% | 0.01% |
| RHUMBLINE ADVISERS | 05/12/2026 | 4.73 K | $6.06 K | -9.03% | 0.01% |
| UBS GROUP AG | 05/05/2026 | 861 | $1.10 K | -9.08% | 0.00% |
| GAMMA INVESTING LLC | 04/06/2026 | 240 | $307 | -77.63% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 10 | $14 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 2 | $3 | 100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| OLD MISSION CAPITAL LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Innate Pharma institutional Ownership - FAQ's
During the previous two years, 13 institutional investors and hedge funds held shares of Innate Pharma. The most heavily invested institutionals were:
Lion Point Capital, LP: 81,151
MORGAN STANLEY: 43,524
JANE STREET GROUP, LLC: 43,365
MILLENNIUM MANAGEMENT LLC: 10,064
RHUMBLINE ADVISERS: 4,734
UBS Group AG: 861
0.20% of Innate Pharma stock is owned by institutional investors.
Institutional investors have bought a total of 183.97 K shares in the last 24 months. This purchase volume represents approximately $290.67 K in transactions.